Browse > Home / Marketing, Partners & Alliances, Products & Solutions, Telehealth, Vendor Watch / Intel Health Guide Enters UK Market with GE-Intel Alliance Expansion

Intel Health Guide Enters UK Market with GE-Intel Alliance Expansion

January 8, 2010

With intents to aid care providers in addressing the increase in chronic diseases and conditions associated with the aging population, GE Healthcare and Intel Corporation have entered into an agreement to expand the sales and marketing of the Intel® Health Guide to the United Kingdom.

As a comprehensive remote patient monitoring (RPM) solution, the Intel Health Guide aids in the management of care for chronic conditions. The care management tool unifies the power of Intel Health Guide PHS6000, an in-home patient equipment, and Intel® Health Care Management Suite, a Web-based interface that facilitates monitoring and remote care management. The solution is equipped with patient reminders, vital sign collection capabilities, communication tools like alerts and video conferencing, and also allows self-monitoring of the health condition by patients. The U.S. Food and Drug Administration (FDA)-approved solution was recognized by Frost & Sullivan with the 2009 North American Home Health Devices Product of the Year Award.

Backing the home care service model, which enables care delivery for the elderly population in independent living and the management of chronic diseases by patients from home, Mariah Scott, Director of Sales and Marketing of the Intel Digital Health Group, states that the concept of technology-backed home care, is fundamental to the establishment of a cost-effective and personalized healthcare system.

With GE Healthcare already involved in the marketing of the product in the United States, Intel hopes to leverage the vendor’s disease management expertise and distribution footprint across UK’s healthcare sector, to enhance the understanding of the technology across the UK telehealth market.

For GE, the agreement is expected to further extend its Home Health business, adding to its other ventures in patient monitoring and disease diagnosis, which are already established in the UK. The company has been involved in providing services to the National Health Service (NHS) and the nation’s private health sector for over 30 years. Additionally, the company hopes that the move will contribute to various pilot programs and policy development initiatives of NHS and the Department of Health, in the field of home care management.

The announcement of the product’s release in UK has been preceded by many ongoing pilot programs to test the competence of the Health Guide in enhancing home healthcare management.

The current alliance follows a $250 million investment across five years, made by both the companies in April 2009 for the research, development and distribution of home health technologies. The marketing of Intel’s Health Guide across the US, was included in the deal. Intel’s recognized expertise in technology development and ethnographic research, along with GE’s potency in global distribution of electronic medical records, critical care, healthcare IT, and passive monitoring, was viewed as a robust strategic fit for the alliance.

The common vision of using technology for bringing about efficient home-based healthcare services for the elderly and patients suffering from chronic conditions has been depicted by the various efforts of both companies in delivering various products, initiatives and strategic moves to support connected health in a broad perspective.

GE Healthcare

  • Acquired QuietCare®, a remote behavioral and passive activity monitoring system, from Living Independently Group, Inc. in December 2009

  • Acquired VersaMed Corporation and Vital Signs Inc., both catering to the home care arena

  • Signed a $5.3 million, three-year contract for collaborative research program on home care, funded by the Hungarian Government

    • Intel Corporation

  • Established a $30 million Technology Research for Independent Living Centre through a contract with the Irish Development Agency

  • Developed the Telehealth Value Model, which acts as a framework to help detect and assess value generated by telecare and telehealth programs

    • According to the UK Department of Health, nearly 17.5 million adults and almost three-quarters of the population aged above 75 years in Great Britain could be inflicted with a chronic disease. Further, the department estimates that by 2030, the incidence will be two-fold in people above 65 years of age. The growing care requirements among the elderly population could be managed by extending the delivery of care from the healthcare facilities to the home, which could in turn open up potential opportunities in the home health monitoring and telehealth market. Based on the combined US and Europe estimates, Data Monitor anticipates the home health monitoring and telehealth market to soar from $3 billion in 2009 to approximately $7.7 billion by 2012.

    Written by The HealthNEWS.Direct! Team · Filed Under Marketing, Partners & Alliances, Products & Solutions, Telehealth, Vendor Watch 

    Please rate this Article:

    Stay ahead of competition with HealthNEWS.Direct!
    To receive the latest updates and news alerts, please register and receive full content access, and also receive more information about our quarterly magazine. Subscription can be done online using a secure payment link. To learn more, please click here


    Comments

    Comments are closed.